Estudos de relação estrutura atividade e docking - UFRJ

887 REFERÊNCIAS BIBLIOGRÁFICASABRAHAM, D. J. Burguer's Medicinal Chemistry & Drug Discovery. Wiley-Interscience, ed., 2003.ARDUINO, P. G.; PORTER, S. R. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review ofits management. Oral Dis, v. 12, 3, p. 254-70, 2006.ARNOLD, K.; BORDOLI, L.; KOPP, J.; SCHWEDE, T. The SWISS-MODEL workspace: a web-basedenvironment for protein structure homology modelling. Bioinformatics, v. 22, 2, p. 195-201, 2006.ARROIO, A.; HONÓRIO, K. M.; SILVA, A. B. F. D. Propriedades químico-quânticas empregadas em estudosdas relações estrutura-atividade. Química Nova, v. 33, p. 694-699, 2010.ARROYO, E.; CHINCHILLA, N.; MOLINILLO, J. M.; MACIAS, F. A.; ASTOLA, A.; ORTIZ, M.;VALDIVIA, M. M. Aneugenic effects of benzoxazinones in cultured human cells. Mutat Res, v. 695, 1-2, p.81-6, 2010.BABE, L. M.; CRAIK, C. S. Viral proteases: evolution of diverse structural motifs to optimize function. Cell, v.91, 4, p. 427-30, 1997.BAINES, J. D. Herpes simplex virus capsid assembly and DNA packaging: a present and future antiviral drugtarget. Trends Microbiol, v. 19, 12, p. 606-13, 2011.BARREIRO , E. J. A Química Medicinal e o paradigma do composto-protótipo. RVQ, v. 1, 1, p. 26-34, 2009.BARREIRO, E. J.; RODRIGUES, C. R.; ALBUQUERQUE, M. G.; SANT'ANNA, C. M. R. D.;ALENCASTRO, R. B. D. Modelagem Molecular: Uma Ferramenta para o Planejamento Racional de Fármacosem Química Medicinal. Química Nova, v. 20, p. 300-310, 1997.BEHRENS-BAUMANN, W. Herpes simplex keratitis. A short overview of the current therapy. Klin MonblAugenheilkd, v. 227, 5, p. 388-92, 2010.BISSANTZ, C.; KUHN, B.; STAHL, M. A medicinal chemist's guide to molecular interactions. J Med Chem,v. 53, 14, p. 5061-84, 2010.BODE, W.; MEYER, E., JR.; POWERS, J. C. Human leukocyte and porcine pancreatic elastase: X-ray crystalstructures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry, v. 28, 5, p. 1951-63, 1989.BOND, C. S.; SCHUTTELKOPF, A. W. ALINE: a WYSIWYG protein-sequence alignment editor forpublication-quality alignments. Acta Crystallogr D Biol Crystallogr, v. 65, Pt 5, p. 510-2, 2009.BOWIE, J. U.; LUTHY, R.; EISENBERG, D. A method to identify protein sequences that fold into a knownthree-dimensional structure. Science, v. 253, 5016, p. 164-70, 1991.BUISSON, M.; HERNANDEZ, J. F.; LASCOUX, D.; SCHOEHN, G.; FOREST, E.; ARLAUD, G.;SEIGNEURIN, J. M.; RUIGROK, R. W.; BURMEISTER, W. P. The crystal structure of the Epstein-Barr virusprotease shows rearrangement of the processed C terminus. J Mol Biol, v. 324, 1, p. 89-103, 2002.BUISSON, M.; RIVAIL, L.; HERNANDEZ, J. F.; JAMIN, M.; MARTINEZ, J.; RUIGROK, R. W.;BURMEISTER, W. P. Kinetics, inhibition and oligomerization of Epstein-Barr virus protease. FEBS Lett, v.580, 28-29, p. 6570-8, 2006.CHIDA, Y.; MAO, X. Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A metaanalyticinvestigation on prospective studies. Brain Behav Immun, v. 23, 7, p. 917-25, 2009.CHONO, K.; KATSUMATA, K.; KONTANI, T.; KOBAYASHI, M.; SUDO, K.; YOKOTA, T.; KONNO, K.;SHIMIZU, Y.; SUZUKI, H. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against